Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Biodexa Pharmaceuticals PLC BDRX

Metals & Mining Gold
Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BDRX)

Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary

GlobeNewswire 8 days ago

Biodexa Announces Pricing of $10 Million Public Offering

GlobeNewswire December 18, 2025

Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAP

GlobeNewswire December 1, 2025

Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP

GlobeNewswire November 24, 2025

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

GlobeNewswire November 3, 2025

Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA - IGC Conference on October 11, 2025

GlobeNewswire October 6, 2025

Interim results for the six months ended June 30, 2025

GlobeNewswire September 12, 2025

Biodexa Moves Into Phase 3 With eRapa For FAP With First Patients Enrolled

ACCESS Newswire September 8, 2025

Biodexa Announces Enrolment of First Patients into Pivotal Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)

GlobeNewswire August 18, 2025
View More News ››

Opinion & Analysis (NDAQ:BDRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BDRX)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - December 16, 2025

Buy buddy buy.

Otherwise FOMO for you fellas out there today anyway
coolfooldumbguy - December 15, 2025

BDRX..... Volume & Price Action this week & NR

27 million shares have traded for the last 5 business days....and guess what ? All this pomp to bury The Greater Fool with high priced...
Iseneschal - December 10, 2025

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - October 9, 2025

Using technical analysis for this stock.

It is starting to break out to the upside today and it is going to be taking off soon
coolfooldumbguy - March 19, 2025

Buy buddy buy because it's taking off this morning.

It's got approval from the FDA,so that it's time to buy it.
coolfooldumbguy - February 10, 2025
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas in ...
View More »

Podcasts